Showing results (121-130 of 131) with videos related to
Sort By:
Pageof 14
Biomolecules|April 3, 2021
Parallel Multi-Omics in High-Risk Subjects for the Identification of Integrated Biomarker Signatures of Type 1 DiabetesOscar Alcazar, Luis F Hernandez, Ernesto S Nakayasu, et al.Clinical Lung Cancer|June 22, 2025
Phase II Trial of LP-300 in Combination With Carboplatin and Pemetrexed in Never Smoker Patients With Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatment With Tyrosine Kinase InhibitorsJ Nicholas Bodor, Jonathan Dowell, Joseph Treat, et al.Neurology|February 15, 2013
Octanoic acid in alcohol-responsive essential tremor: a randomized controlled studyDietrich Haubenberger, Gayle McCrossin, Codrin Lungu, et al.Clinical Lung Cancer|July 14, 2023
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never SmokedJ Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, et al.Diabetologia|May 16, 2019
In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD miceMidhat H Abdulreda, R Damaris Molano, Gaetano Faleo, et al.Diabetologia|June 14, 2019
Correction to: In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD miceMidhat H Abdulreda, R Damaris Molano, Gaetano Faleo, et al.Proceedings of the National Academy of Sciences of the United States of America|January 20, 2021
Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fractionAngela C Rieger, Luiza L Bagno, Alessandro Salerno, et al.Stem Cell Reports|February 19, 2019
A Double Fail-Safe Approach to Prevent Tumorigenesis and Select Pancreatic β Cells from Human Embryonic Stem CellsMirza Muhammad Fahd Qadir, Silvia Álvarez-Cubela, Kinsley Belle, et al.Nature Communications|July 3, 2025
Pancreatic β-cell regeneration in situ by the ALK3 agonist THR-123Silvia Álvarez-Cubela, Isabella D Altilio, Mayur Doke, et al.Nature Communications|March 13, 2026
Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human studyYonina R Murciano-Goroff, Antoine Hollebecque, Rebecca S Heist, et al.Pageof 14